Question:

All of the following decrease bone resorption in osteoporosis except?

Show Hint

One of these builds bone (anabolic PTH) rather than blocking osteoclasts.
Updated On: Jun 24, 2026
  • Alendronate
  • Etidronate
  • Strontium
  • Teriparatide
Show Solution
collegedunia
Verified By Collegedunia

The Correct Option is D

Solution and Explanation

Step 1: Osteoporosis drugs fall into two groups: ANTIRESORPTIVE agents (which inhibit osteoclasts and reduce bone breakdown) and ANABOLIC agents (which stimulate osteoblasts and build new bone). The question asks for the one that does NOT decrease bone resorption.
Step 2: Alendronate and Etidronate are bisphosphonates. They concentrate in bone and inhibit osteoclast-mediated resorption, so both are antiresorptive.
Step 3: Strontium ranelate has a dual action but is classically grouped with antiresorptive agents because it reduces osteoclastic bone resorption (while also mildly promoting formation).
Step 4: Teriparatide is recombinant parathyroid hormone (PTH 1-34). Given as intermittent daily injections, it is an ANABOLIC drug that stimulates osteoblasts and increases bone FORMATION rather than decreasing resorption. Hence it is the exception.
Conclusion: The correct answer is Teriparatide, matching the printed key.
Was this answer helpful?
0
0